Glenmark Pharmaceuticals Limited (GLENMARK) advances its multi-country Phase 3 clinical trial for Trastuzumab rezetecan in platinum-resistant ovarian cancer.
Suven Life Sciences Limited (SUVEN) announces positive DSMB safety review and interim analysis from ongoing global Phase 3 study of Masupirdine in Alzheimer'.